Photo from CPE/LinkedIn
Jul 11, 2024, 15:38
Call to Action on the implementation of Joint Clinical Assessment for ATMPs
Cancer Patients Europe (CPE) shared on LinkedIn:
“CPE, in collaboration with the Alliance for Regenerative Medicine and Fondazione Telethon, has launched a Call to Action on the implementation of the EU Joint Clinical Assessment (JCAs) for Advanced Therapy Medicinal Products (ATMPs).
With the support of more than 30 signatories, we are urging the HTA Coordination Group and JCA assessors to ensure that JCA methodologies do not hinder Patient Access and the innovation of ATMPs in Europe.
Read the press release.”
Source: CPE/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 17:53
Apr 19, 2025, 17:17
Apr 19, 2025, 17:01
Apr 19, 2025, 16:44
Apr 19, 2025, 16:23